CLRPF
Price
$2.12
Change
+$0.10 (+4.95%)
Updated
Sep 4 closing price
Capitalization
771.57M
TELIF
Price
$0.27
Change
-$0.02 (-6.90%)
Updated
Sep 4 closing price
Capitalization
14.21M
Interact to see
Advertisement

CLRPF vs TELIF

Header iconCLRPF vs TELIF Comparison
Open Charts CLRPF vs TELIFBanner chart's image
Clarity Pharmaceuticals
Price$2.12
Change+$0.10 (+4.95%)
Volume$13.37K
Capitalization771.57M
TELESCOPE INNOVATIONS
Price$0.27
Change-$0.02 (-6.90%)
Volume$5.1K
Capitalization14.21M
CLRPF vs TELIF Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. TELIF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a StrongBuy and TELIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLRPF: $2.12 vs. TELIF: $0.27)
Brand notoriety: CLRPF and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 237% vs. TELIF: 9%
Market capitalization -- CLRPF: $771.57M vs. TELIF: $14.21M
CLRPF [@Biotechnology] is valued at $771.57M. TELIF’s [@Biotechnology] market capitalization is $14.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, TELIF is a better buy in the long-term than CLRPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 4 TA indicator(s) are bullish while TELIF’s TA Score has 4 bullish TA indicator(s).

  • CLRPF’s TA Score: 4 bullish, 6 bearish.
  • TELIF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TELIF is a better buy in the short-term than CLRPF.

Price Growth

CLRPF (@Biotechnology) experienced а +8.72% price change this week, while TELIF (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLRPF($772M) has a higher market cap than TELIF($14.2M). TELIF YTD gains are higher at: 2.301 vs. CLRPF (-21.627). TELIF has higher annual earnings (EBITDA): -1.32M vs. CLRPF (-66.98M).
CLRPFTELIFCLRPF / TELIF
Capitalization772M14.2M5,437%
EBITDA-66.98M-1.32M5,093%
Gain YTD-21.6272.301-940%
P/E RatioN/A85.38-
RevenueN/A3.97M-
Total CashN/A1.11M-
Total DebtN/A2.22M-
TECHNICAL ANALYSIS
Technical Analysis
CLRPFTELIF
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
67%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LOGSX21.120.19
+0.91%
Live Oak Health Sciences
PSCRX16.01N/A
N/A
Putnam Small Cap Value R
PFPRX61.70N/A
N/A
Parnassus Mid Cap Growth Institutional
FGHMX131.37N/A
N/A
Fidelity Advisor Communication ServicesC
JMVYX38.35N/A
N/A
JPMorgan Mid Cap Value R6

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and ENLV have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and ENLV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
N/A
ENLV - CLRPF
22%
Poorly correlated
-0.93%
JBPHF - CLRPF
14%
Poorly correlated
N/A
MLTX - CLRPF
11%
Poorly correlated
-0.47%
TELIF - CLRPF
10%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
-0.88%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
N/A
ATNM - TELIF
28%
Poorly correlated
-6.51%
ELEV - TELIF
24%
Poorly correlated
N/A
RVXCF - TELIF
23%
Poorly correlated
-9.19%
TNFA - TELIF
23%
Poorly correlated
-8.59%
PMN - TELIF
20%
Poorly correlated
N/A
More